November 17, 2025

Drax upgrades ageing hydro station with £15m capacity-backed investment

Drax is upgrading a 1930s Scottish hydro plant with a £15m investment tied to a 15-year capacity contract...

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 65% Upside Potential in Biotech Innovation

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a formidable player in the biotechnology sector, with a market capitalization of $10.51 billion. Specializing in therapies for rare..

Waystar Holding Corp. (WAY) Stock Analysis: A 40.62% Potential Upside in the Health Information Sector

Waystar Holding Corp. (WAY), a key player in the healthcare information services industry, is capturing investor attention with its potential upside of 40.62%. This Utah-based company..

Masimo Corporation (MASI) Stock Analysis: Exploring a 23% Potential Upside for Investors

Masimo Corporation (NASDAQ: MASI), a key player in the healthcare sector, specifically in the medical devices industry, offers a compelling investment opportunity with a notable 23.18%..

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Genetic Sequencing Giant’s Potential Amid Market Volatility

Illumina, Inc. (NASDAQ: ILMN), a key player in the healthcare sector’s diagnostics and research industry, is at the forefront of genetic and genomic analysis worldwide. With..

HealthEquity, Inc. (HQY): Investor Outlook Highlights 18% Upside Potential

For investors seeking to capitalize on growth in the healthcare sector, HealthEquity, Inc. (NASDAQ: HQY) presents an intriguing opportunity. Specializing in technology-enabled services for health savings..

Doximity, Inc. (DOCS) Investor Outlook: Analyzing a 39.16% Potential Upside in the Healthcare Sector

Investors with a keen eye on healthcare technology stocks should take note of Doximity, Inc. (NYSE: DOCS), a prominent player in the health information services industry...

Henry Schein, Inc. (HSIC) Stock Analysis: Insights into a Healthcare Giant with a 7.80% Potential Upside

Investors eyeing the healthcare sector may want to consider Henry Schein, Inc. (NASDAQ: HSIC), a leading player in medical distribution with a robust market capitalization of..

Edwards Lifesciences Corporation (EW) Stock Analysis: Navigating Growth with a Potential 8.86% Upside

Edwards Lifesciences Corporation (NYSE: EW), a leading player in the medical devices industry, is a company that has built its reputation on delivering innovative cardiovascular solutions...

Elanco Animal Health (ELAN) Stock Analysis: Evaluating Growth Potential Amid a 12.94% Upside

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a prominent player in the healthcare sector, specifically within the niche of drug manufacturers focusing on specialty and..

Grifols, S.A. (GRFS) Investor Outlook: Analyzing a 43.8% Potential Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS) is a notable player in the healthcare sector, specifically within the drug manufacturing industry, with a strong foothold in the plasma therapeutics..

Bruker Corporation (BRKR) Stock Analysis: A Look at Its 14.89% Potential Upside

Bruker Corporation (NASDAQ: BRKR), a formidable player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors. With a market..

argenx SE (ARGX) Stock Analysis: A Biotech Leader with a 4.62% Upside

Investors looking into the biotechnology sector may find argenx SE (ARGX) a compelling opportunity. With a market capitalization of $55.9 billion, this Netherlands-based company has gained..

Insulet Corporation (PODD) Stock Analysis: Target Price Suggests 12% Upside Potential

As the healthcare sector continues to evolve with rapid technological advancements, Insulet Corporation (NASDAQ: PODD) stands out as a key player in the medical devices industry...

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Exploring a 4.14% Potential Upside in Biotechnology’s Rising Star

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a promising player in the biotechnology sector, is gaining traction among investors for its innovative approach to tackling metabolic dysfunction-associated steatohepatitis..

BridgeBio Pharma (BBIO) Investor Outlook: Riding a Wave of 4,318% Revenue Growth and Intriguing Upside Potential

BridgeBio Pharma, Inc. (NASDAQ: BBIO) has captured investor attention within the biotechnology space, primarily due to its remarkable revenue growth and compelling potential for upside. The..

Gilead Sciences, Inc. (GILD) Rating Update: Strong Buy Ratings with a 4.47% Potential Upside

Gilead Sciences, Inc. (NASDAQ: GILD), a heavyweight in the healthcare sector, continues to capture investor interest with its formidable presence in the biopharmaceutical landscape. With a..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Strong Buy Ratings Highlight a Promising 14.70% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV) has captured the attention of investors and analysts alike, operating at the cutting edge of the biotechnology sector. With its roots..

Cardinal Health, Inc. (CAH) Stock Analysis: Navigating Growth with a 3.44% Upside Potential

Cardinal Health, Inc. (NYSE: CAH), a stalwart in the healthcare sector, presents a compelling opportunity for investors as it continues to demonstrate robust growth and strategic..

Corcept Therapeutics (CORT) Stock Analysis: A Promising 79% Upside in the Biotech Sector

For investors seeking opportunities within the biotechnology sector, Corcept Therapeutics Incorporated (NASDAQ: CORT) presents a compelling case. With a market capitalization of $7.97 billion, this Redwood..

Search

Funds

November 17, 2025

Drax upgrades ageing hydro station with £15m capacity-backed investment

Drax is upgrading a 1930s Scottish hydro plant with a £15m investment tied to a 15-year capacity contract...
Search

Funds

November 17, 2025

FTSE 100

Funds